Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 3
2014 5
2015 4
2016 4
2017 9
2018 7
2019 5
2020 5
2021 18
2022 7
2023 7
2024 5
2025 6
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Grünig E, Kopeć G, Meyer G, Olsson KM, Rosenkranz S, Xu Y, Miller B, Fowler M, Butler J, Koglin J, de Oliveira Pena J, Humbert M; STELLAR Trial Investigators. Hoeper MM, et al. N Engl J Med. 2023 Apr 20;388(16):1478-1490. doi: 10.1056/NEJMoa2213558. Epub 2023 Mar 6. N Engl J Med. 2023. PMID: 36877098 Clinical Trial.
Sotatercept for the Treatment of Pulmonary Arterial Hypertension.
Humbert M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R, Waxman A, Escribano Subias P, Feldman J, Meyer G, Montani D, Olsson KM, Manimaran S, Barnes J, Linde PG, de Oliveira Pena J, Badesch DB; PULSAR Trial Investigators. Humbert M, et al. N Engl J Med. 2021 Apr 1;384(13):1204-1215. doi: 10.1056/NEJMoa2024277. N Engl J Med. 2021. PMID: 33789009 Clinical Trial.
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
McLaughlin VV, Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Preston IR, Souza R, Waxman AB, Kopeć G, Meyer G, Olsson KM, Fu W, Shi Y, Miller B, Kim SS, Mackenzie HS, Brambatti M, Patel MJ, Koglin J, Cornell AG, Humbert M; HYPERION Trial Investigators. McLaughlin VV, et al. N Engl J Med. 2025 Oct 23;393(16):1599-1611. doi: 10.1056/NEJMoa2508170. Epub 2025 Sep 30. N Engl J Med. 2025. PMID: 41025556 Clinical Trial.
Lymphangioleiomyomatosis: Searching for potential biomarkers.
Revilla-López E, Ruiz de Miguel V, López-Meseguer M, Berastegui C, Boada-Pérez M, Mendoza-Valderrey A, Arjona-Peris M, Zapata-Ortega M, Monforte V, Bravo C, Roman A, Gómez-Ollés S, Sáez-Giménez B. Revilla-López E, et al. Among authors: berastegui c. Front Med (Lausanne). 2023 Feb 2;10:1079317. doi: 10.3389/fmed.2023.1079317. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36817769 Free PMC article.
Acquired tracheomalacia due to SARS-CoV-2 pneumonia.
Espejo D, Zapata M, Omari S, Muñoz X, Cruz MJ; Se‐COVID‐19 team. Espejo D, et al. Clin Respir J. 2024 Jan;18(1):e13719. doi: 10.1111/crj.13719. Epub 2023 Dec 20. Clin Respir J. 2024. PMID: 38666787 Free PMC article.
Biomarkers of pulmonary rejection.
Berastegui C, Román J, Monforte V, Bravo C, López-Meseguer M, Montero MÁ, Culebras M, Gómez-Ollés S, Román A. Berastegui C, et al. Transplant Proc. 2013 Nov;45(9):3163-9. doi: 10.1016/j.transproceed.2013.06.013. Transplant Proc. 2013. PMID: 24182778 Review.
Safety and efficacy of immunoguided prophylaxis for cytomegalovirus disease in low-risk lung transplant recipients in Spain: a multicentre, open-label, randomised, phase 3, noninferiority trial.
Páez-Vega A, Vaquero-Barrios JM, Ruiz-Arabi E, Iturbe-Fernández D, Alonso R, Ussetti-Gil P, Monforte V, Pastor A, Fernández-Moreno R, Mora VM, Erro-Iribarren M, Quezada CA, Berastegui C, Cifrian-Martínez JM, Cano A, Castón JJ, Machuca I, Lobo-Acosta MA, Gutiérrez-Gutiérrez B, Cantisán S, Torre-Cisneros J; CYTOCOR study group. Páez-Vega A, et al. Among authors: berastegui c. Lancet Reg Health Eur. 2025 Mar 26;52:101268. doi: 10.1016/j.lanepe.2025.101268. eCollection 2025 May. Lancet Reg Health Eur. 2025. PMID: 40224372 Free PMC article.
Discordance between humoral and cellular immune responses to cytomegalovirus infection in CMV seropositive patients awaiting lung transplantation.
Boada-Pérez M, Berastegui C, Erro M, Ussetti P, Crespo E, Donadeu L, Bestard O, Anguera G, Solé A, Ponz Mir R, Molloy B, Revilla-López E, Monforte V, Gómez-Ollés S. Boada-Pérez M, et al. Among authors: berastegui c. Front Immunol. 2025 Jan 22;15:1445553. doi: 10.3389/fimmu.2024.1445553. eCollection 2024. Front Immunol. 2025. PMID: 39911579 Free PMC article.
Lung transplantation in HIV-positive patients: a European retrospective cohort study.
Rouzaud C, Berastegui C, Picard C, Vos R, Savale L, Demant X, Bertani A, Verschuuren E, Jaksch P, Reed A, Morlacchi LC, Reynaud-Gaubert M, Lortholary O, Fadel E, Humbert M, Gottlieb J, Le Pavec J. Rouzaud C, et al. Among authors: berastegui c. Eur Respir J. 2022 Jul 13;60(1):2200189. doi: 10.1183/13993003.00189-2022. Print 2022 Jul. Eur Respir J. 2022. PMID: 35595318 Free article. No abstract available.
73 results